DNA SEQUENCING MARKET ANALYSIS

DNA Sequencing Market, by Product Type (Consumables, Instruments, and Services), by Technology (Sanger Sequencing, Next-Generation Sequencing, Third- Generation DNA Sequencing, and Others), by Application (Oncology, Reproductive Health, Clinical Investigation, Agrigenomics & Forensics, Metagenomics, Epidemiology & Drug Development, and Others), by End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Clinical Research, and Others), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Feb 2023
Code : CMI5531
Pages :208
Formats :
Excel and PDF
Industry : Pharmaceutical

DNA Sequencing MarketSize and Trends

Global DNA sequencing market is estimated to be valued at US$ 6,802.2 million in 2023 and is expected to exhibit a CAGR of 11.7% during the forecast period (2023-2030).

Global DNA Sequencing Market- Driver

Increasing research and development activity

The DNA sequencing is used in research and development of drugs. Thus, increasing research and development activity by key players in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in January 2022, a rare genetic disorder was diagnosed in an average of 8 hours, using a new ultrafast genome sequencing approach developed by scientists at Stanford University School of Medicine and their collaborators. Genome sequencing allowed scientists to see a patient's complete DNA structure, this included information on everything such as from eye color to genetic diseases. Genome sequencing is essential in diagnosing patients with DNA-rooted diseases.